The South Plains Oncology Consortium (SPOC) is a regional consortium devoted to conducting early phase oncology trials and translational cancer research.

A major goal of SPOC is to improve access for new anti-cancer drugs to patients in West Texas and the surrounding region.

Latest News

  • March 2020
    Due to multiple issues related to the COVID-19 pandemic, some SPOC clinical trials will be suspended to accrual. Any trials suspended will be noted on this website, and when open to accrual, we will also note that on this website. At the current time this only applies to therapeutic clinical trials and the TR-01 biobanking study remains open to accrual.
    read more »

© South Plains Oncology Consortium (2008-2022)